• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>AstraZeneca PLC ADR

AstraZeneca PLC ADR

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Aerie Pharmaceuticals Announces Appointment of Raymond S. Wysmierski as Director of Compliance

    Aerie Pharmaceuticals Announces Appointment of Raymond S. Wysmierski as Director of Compliance

  2. UPDATE: Tesaro stock dives 7% after drug pricing snafu

    UPDATE: Tesaro stock dives 7% after drug pricing snafu

  3. Tesaro's new ovarian drug will cost cancer patients $60,000 to $177,000 a year

    Tesaro's new ovarian drug will cost cancer patients $60,000 to $177,000 a year

  4. UPDATE: Tesaro drug pricing snafu sends stock down 3% and lifts rival drugmaker's shares

    UPDATE: Tesaro drug pricing snafu sends stock down 3% and lifts rival drugmaker's shares

  5. Sosei Subsidiary Heptares to Receive US$12 Million Milestone Payment from AstraZeneca

    Sosei Subsidiary Heptares to Receive US$12 Million Milestone Payment from AstraZeneca

  6. US Healthcare Advertising 2017-2021: Increasing Presence of Generic and Me-too Drugs - Major Players are Johnson & Johnson, Pfizer, Merck & Co., GlaxoSmithKline and Roche - Research and Markets

    US Healthcare Advertising 2017-2021: Increasing Presence of Generic and Me-too Drugs - Major Players are Johnson & Johnson, Pfizer, Merck & Co., GlaxoSmithKline and Roche - Research and Markets

  7. LONDON MARKETS: U.K. Stocks Break 3-day Losing Streak As Gold Miners Rise

    LONDON MARKETS: U.K. Stocks Break 3-day Losing Streak As Gold Miners Rise

  8. U.K. stocks break 3-day losing streak as gold miners rise

    U.K. stocks break 3-day losing streak as gold miners rise

  9. LONDON MARKETS: U.K. Stocks Break 3-day Losing Streak As Gold Miners Rise

    LONDON MARKETS: U.K. Stocks Break 3-day Losing Streak As Gold Miners Rise

  10. UPDATE: U.K. stocks break 3-day losing streak as gold miners rise

    UPDATE: U.K. stocks break 3-day losing streak as gold miners rise

12345

©2017 Morningstar Advisor. All right reserved.